The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Cusp Overlap Technique During Valve-in-Valve TAVI Using the Novel Navitor Transcatheter Heart Valve

DOI: 10.4244/EIJ-D-21-00592

1. The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, Denmark

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

A 67-year-old male was referred for valve-in-valve (VIV) transcatheter aortic valve implantation (TAVI) in view of symptomatic, severe structural valve deterioration of a 23 mm Perimount 2800 (Edwards Lifesciences, USA) implanted 12 years earlier due to a severely stenotic bicuspid aortic valve. Latest transthoracic echocardiography showed a mean trans-prosthetic gradient of 80 mmHg, but no regurgitation. Pre-procedural computed tomography (CT) revealed adequate virtual valve-to-coronary distances (> 4 mm) (Figure 1A). The patient was scheduled for VIV-TAVI with a 25 mm Navitor™ (Abbott, USA) under local anesthesia. Compared to the Portico™ system (Abbott, USA), this latest-generation Navitor™ transcatheter heart valve (THV; Figure 1B) has an active outer NaviSeal™ cuff to prevent paravalvular leakage (PVL), optimized radial force, and a curved aortic outflow part to mitigate risk of aortic injury.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
A EuroIntervention State of the Art on the management of cardiogenic shock; intravascular hypothermia as adjunctive therapy for primary PCI; dual therapy with dabigatran plus a P2Y₁₂ inhibitor in STEMI patients with atrial fibrillation; a trial of balloon-based techniques for severely calcified coronary lesions; neoatherosclerosis after PCI for in-stent restenosis; antithrombotic therapy for coronary erosions; a mini focus on spontaneous coronary artery dissection, and more…